IDEAYA Biosciences IDYA
NASDAQ IDYA
$31.75 -0.28 (-0.87%)
At close: Nov 10, 2026 · 4:00 PM EST

IDEAYA Biosciences (IDYA) Cash from Financing Activities (2018 - 2026)

Updated

IDEAYA Biosciences (IDYA) posted Cash from Financing Activities of $3.7 million for Q3 2026, compared with $301,000 a year earlier and down 99.0% from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Cash from Financing Activities (2018 - 2026) Analysis & Trends

For the trailing twelve months through Sep 30, 2026, Cash from Financing Activities at IDEAYA Biosciences was $366.22 million; for FY2025, it was $29.78 million, down 95.6% from FY2024.

  • Annual Cash from Financing Activities shows a five-year compound annual growth rate of -25.4% (FY2020 to FY2025).
  • In prior years, IDEAYA Biosciences' Cash from Financing Activities was $677.55 million in FY2024 (+86.8%), $362.72 million in FY2023 (+273.3%), $97.17 million in FY2022 (-33.2%) and $145.45 million in FY2021 (+13.0%).
  • Quarterly Cash from Financing Activities has run from a low of $301,000 in Q3 2025 to a high of $359.21 million in Q2 2026 over five years.
  • The strongest year-over-year quarter for Cash from Financing Activities in the past five years was Q3 2024, with growth of 929.3%; the weakest was Q3 2025, with a decline of 99.9%.
  • According to Business Quant data, Cash from Financing Activities for the three prior quarters was $359.21 million (Q2 2026), $1.18 million (Q1 2026) and $2.13 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -7.22 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -8.53 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 6.82 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -2.43 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 6.63 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -4.39 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -1.53 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -2.51 Bn
10 IDEAYA Biosciences 3.07 Bn 90.55 Mn - 3.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 3.70 Mn
Jun 30, 2026 359.21 Mn
Mar 31, 2026 1.18 Mn
Dec 31, 2025 2.13 Mn
Sep 30, 2025 301,000.00
Jun 30, 2025 1.21 Mn
Mar 31, 2025 26.14 Mn
Dec 31, 2024 2.75 Mn
Sep 30, 2024 286.50 Mn
Jun 30, 2024 39.18 Mn
Mar 31, 2024 349.11 Mn
Dec 31, 2023 140.89 Mn
Sep 30, 2023 27.83 Mn
Jun 30, 2023 191.06 Mn
Mar 31, 2023 2.93 Mn
Dec 31, 2022 324,000.00
Sep 30, 2022 95.70 Mn
Jun 30, 2022 491,000.00
Mar 31, 2022 653,000.00
Dec 31, 2021 688,000.00
API Access

IDEAYA Biosciences Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=IDYA&period=max&api_key=YOUR_API_KEY